FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124308399> ?p ?o ?g. }

• W2124308399 endingPage "88" @default.
• W2124308399 startingPage "88" @default.
• W2124308399 abstract "<b>Background:</b> Fluconazole has shown to be effective in reducing both colonization and invasive Candida infection (ICI) in ELBW neonates; we conducted a randomized trial to compare oral nystatin with intravenous fluconazole for prophylaxis against invasive Candidiasis in high risk neonates. <b>Materials and Methods:</b> By using SPSS, preterm less than 30 weeks gestation and/or birth weight 1200 grams or less assigned to receive either intravenous Fluconazole (6 mg/kg q72 hr for 1 ^st week then q48 h for 6 wks) or oral Nystatin (100,000 unit q8 hr for 6 wks). The medications commenced at one week of age after obtaining the base line investigations and check for Candida colonization by urine culture and rectal swab; subsequently all lab work and the clinical data were monitered regularly. Risk factors were assessed. The data collected prospectively looking for primary end point the invasive Candida infection (ICI) and 2 ndry outcomes include medication safety, tolerance and cost. <b>Results:</b> 65 neonate randomly assigned however only 57 neonates comleted the study 33/57 (57%) to intravenous fluconazole group and 24/57 (42%) to oral nystatin group. No differences in birth weights Nystatin (1.15 Kg) Fluconazole (1.01 Kg), gender males (26/57), female (32/57), Gestational age (29.28 vs l28.22) or risk factors between the two groups. Rectal swab Colonization occurred in 2/24 (8%) in Nystatin group and 4/33 (12%) in the Fluconazole group, but none of the neonates developed ICI or side effects, although in the Fluconazole group transient transaminase elevation 2SD standard deviation above the mean was observed. Central line duration was 2 SD above the mean for fluconazole group, The cost of the Fluconazole treated group (7,581 SAR) 106.4 US/pt double the cost of Nystatin treated group (3,375 SAR) 50 US/pt. <b>Conclusion:</b> Intravenous Fluconazole and oral Nystatin at the prophylactic doses are equally effective and safe in preventing (ICI) in preterm neonates, however oral Nystatin is readily available, easily administered with lower cost per neonate." @default.
• W2124308399 created "2016-06-24" @default.
• W2124308399 creator A5004593563 @default.
• W2124308399 creator A5029093228 @default.
• W2124308399 creator A5037983350 @default.
• W2124308399 creator A5046889650 @default.
• W2124308399 creator A5064417879 @default.
• W2124308399 creator A5074950204 @default.
• W2124308399 creator A5076920110 @default.
• W2124308399 creator A5082237771 @default.
• W2124308399 creator A5087312314 @default.
• W2124308399 date "2013-01-01" @default.
• W2124308399 modified "2023-09-27" @default.
• W2124308399 title "Oral nystatin versus intravenous fluconazole as neonatal antifungal prophylaxis: Non-inferiority trial" @default.
• W2124308399 cites W1838554279 @default.
• W2124308399 cites W1978728204 @default.
• W2124308399 cites W1985021288 @default.
• W2124308399 cites W1988274583 @default.
• W2124308399 cites W2000701107 @default.
• W2124308399 cites W2017046795 @default.
• W2124308399 cites W2056726034 @default.
• W2124308399 cites W2075517361 @default.
• W2124308399 cites W2092125702 @default.
• W2124308399 cites W2151856768 @default.
• W2124308399 cites W2320070997 @default.
• W2124308399 doi "https://doi.org/10.4103/2249-4847.116408" @default.
• W2124308399 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3775143" @default.
• W2124308399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24049751" @default.
• W2124308399 hasPublicationYear "2013" @default.
• W2124308399 type Work @default.
• W2124308399 sameAs 2124308399 @default.
• W2124308399 citedByCount "20" @default.
• W2124308399 countsByYear W21243083992014 @default.
• W2124308399 countsByYear W21243083992015 @default.
• W2124308399 countsByYear W21243083992016 @default.
• W2124308399 countsByYear W21243083992017 @default.
• W2124308399 countsByYear W21243083992018 @default.
• W2124308399 countsByYear W21243083992020 @default.
• W2124308399 countsByYear W21243083992021 @default.
• W2124308399 countsByYear W21243083992022 @default.
• W2124308399 countsByYear W21243083992023 @default.
• W2124308399 crossrefType "journal-article" @default.
• W2124308399 hasAuthorship W2124308399A5004593563 @default.
• W2124308399 hasAuthorship W2124308399A5029093228 @default.
• W2124308399 hasAuthorship W2124308399A5037983350 @default.
• W2124308399 hasAuthorship W2124308399A5046889650 @default.
• W2124308399 hasAuthorship W2124308399A5064417879 @default.
• W2124308399 hasAuthorship W2124308399A5074950204 @default.
• W2124308399 hasAuthorship W2124308399A5076920110 @default.
• W2124308399 hasAuthorship W2124308399A5082237771 @default.
• W2124308399 hasAuthorship W2124308399A5087312314 @default.
• W2124308399 hasBestOaLocation W21243083992 @default.
• W2124308399 hasConcept C126322002 @default.
• W2124308399 hasConcept C16005928 @default.
• W2124308399 hasConcept C168563851 @default.
• W2124308399 hasConcept C187212893 @default.
• W2124308399 hasConcept C2777091541 @default.
• W2124308399 hasConcept C2777762789 @default.
• W2124308399 hasConcept C2778376644 @default.
• W2124308399 hasConcept C2779234561 @default.
• W2124308399 hasConcept C2779548794 @default.
• W2124308399 hasConcept C2780651595 @default.
• W2124308399 hasConcept C46973012 @default.
• W2124308399 hasConcept C54355233 @default.
• W2124308399 hasConcept C71924100 @default.
• W2124308399 hasConcept C86803240 @default.
• W2124308399 hasConceptScore W2124308399C126322002 @default.
• W2124308399 hasConceptScore W2124308399C16005928 @default.
• W2124308399 hasConceptScore W2124308399C168563851 @default.
• W2124308399 hasConceptScore W2124308399C187212893 @default.
• W2124308399 hasConceptScore W2124308399C2777091541 @default.
• W2124308399 hasConceptScore W2124308399C2777762789 @default.
• W2124308399 hasConceptScore W2124308399C2778376644 @default.
• W2124308399 hasConceptScore W2124308399C2779234561 @default.
• W2124308399 hasConceptScore W2124308399C2779548794 @default.
• W2124308399 hasConceptScore W2124308399C2780651595 @default.
• W2124308399 hasConceptScore W2124308399C46973012 @default.
• W2124308399 hasConceptScore W2124308399C54355233 @default.
• W2124308399 hasConceptScore W2124308399C71924100 @default.
• W2124308399 hasConceptScore W2124308399C86803240 @default.
• W2124308399 hasIssue "2" @default.
• W2124308399 hasLocation W21243083991 @default.
• W2124308399 hasLocation W21243083992 @default.
• W2124308399 hasLocation W21243083993 @default.
• W2124308399 hasLocation W21243083994 @default.
• W2124308399 hasOpenAccess W2124308399 @default.
• W2124308399 hasPrimaryLocation W21243083991 @default.
• W2124308399 hasRelatedWork W1557359740 @default.
• W2124308399 hasRelatedWork W1939342042 @default.
• W2124308399 hasRelatedWork W1965174455 @default.
• W2124308399 hasRelatedWork W2011669597 @default.
• W2124308399 hasRelatedWork W2075623953 @default.
• W2124308399 hasRelatedWork W2076110042 @default.
• W2124308399 hasRelatedWork W2326526783 @default.
• W2124308399 hasRelatedWork W2414057952 @default.
• W2124308399 hasRelatedWork W2969684946 @default.
• W2124308399 hasRelatedWork W32833589 @default.
• W2124308399 hasVolume "2" @default.

• next